GLOBUS MEDICAL INC vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| GMED | SYK | |
|---|---|---|
| Market Cap | $11.53 billion | $130.11 billion |
| Revenue (TTM) | — | $25.84 billion |
| Net Income (TTM) | — | $3.73 billion |
SYK leads on 1 of 1 size & scale factors.
Valuation
| GMED | SYK | |
|---|---|---|
| P/E Ratio | — | 35.15 |
| Price / Book | 2.42 | 5.42 |
| Price / Sales | — | 5.04 |
GMED leads on 1 of 1 valuation factors.
Profitability
| GMED | SYK | |
|---|---|---|
| Net Margin | — | 14.43% |
| Return on Equity | — | 15.55% |
GMED and SYK split the profitability factors evenly.
Dividend
| GMED | SYK | |
|---|---|---|
| Dividend Yield | — | 1.04% |
| Payout Ratio | — | 36.48 |
GMED and SYK split the dividend factors evenly.
Risk & Sentiment
| GMED | SYK | |
|---|---|---|
| Short Interest | 3.12% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: GMED overview, GMED financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.